Filing metadata

Accession number
0001470831-25-000353
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Nov 18, 2025
Reporting period
Nov 16, 2025
Description
Insider transaction

Explore SEC Filings Hub